2018 annual financial data
Cumberland Pharmaceuticals 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was 7.64%.
Operating income was -7,390,772 USD and net income was -6,963,068 USD.
Operating cash flow was 3,112,737 USD.
Get free Cumberland Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 40,741,765 USD
- Operating income
- -7,390,772 USD
- Net income
- -6,963,068 USD
- Operating cash flow
- 3,112,737 USD